688319.SH
欧林生物
SSE · Healthcare · Biotechnology · CN
CNY 27.82
−7.42%Aug 31, 2026, 14:42 UTC
On August 31, 2026, ten A-share listed companies including Olymvax Biopharmaceuticals, Xiaocheng Technology, Hengyin Technology, Xinhongye, Feirongda, Ruison Technology, Weiteng Electric, Jinge New Materials, Baling Oriental, and Bestore disclosed plans to reduce their holdings, while ST Kaili and XCMG disclosed plans to increase holdings.
Source:Aug 31, 2026, 13:11 UTC
Olymvax Biopharmaceuticals director and deputy general manager Chen Aimin plans to reduce his shareholding in the company by up to 0.0338% of total shares.
Source:Aug 17, 2026, 11:16 UTC
Olymvax Biopharmaceuticals reported a net loss of 32.8726 million yuan for the first half of 2026, turning from a profit of 13.1969 million yuan a year earlier, with revenue of 361 million yuan, up 18.14% year-on-year.
Source: